EP1982984A3 — Tricyclic thrombin receptor antagonists
Assigned to Merck Sharp and Dohme LLC · Expires 2008-10-29 · 18y expired
What this patent protects
Process for the manufacture of compounds of the following general formula (II): wherein R x represents a group selected from COOCH 2 CH 3 , SO 2 CH 3 , CONHCH 3 , and COCH 3 , comprising the step of reacting the corresponding primary amine compound with a compound of the …
USPTO Abstract
Process for the manufacture of compounds of the following general formula (II): wherein R x represents a group selected from COOCH 2 CH 3 , SO 2 CH 3 , CONHCH 3 , and COCH 3 , comprising the step of reacting the corresponding primary amine compound with a compound of the general formula R x -X wherein X is a leaving group.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.